Healthcare -
Biotechnology - NASDAQ - US
$ 9.08
-3.64 %
$ 536 M
Market Cap
-3.16
P/E
CGEM - OPERATING INCOME
Operating Income CGEM - Cullinan Oncology, Inc.
-197 M
LAST VALUE
-53.67%
2 YEAR CAGR
-54.64%
5 YEAR CAGR
0.00%
10 YEAR CAGR